forty-seven previously untreated patients with intermediate- or high-grade non-hodgkin 's lymphoma were treated with four courses of a regimen that consisted of high-dose ( 120 mg/m2 ) adriamycin ( doxorubicin ; adria laboratories , columbus , oh ) , vincristine ( 2 mg ) , cytarabine ( 3 gm/m2 ) , and dexamethasone ( 50 mg intravenously [ iv ] on day 1 and 20 mg/day orally on days 2 to 5 ) ( avad ) , which was administered every 3 to 4 weeks .
C0024305
non-hodgkin 's
C0042679
vincristine